Shore Capital Reiterates “House Stock” Rating for Anpario (LON:ANP)

Anpario (LON:ANP)‘s stock had its “house stock” rating reiterated by research analysts at Shore Capital in a note issued to investors on Monday, Marketbeat.com reports.

Separately, Canaccord Genuity Group upped their price objective on Anpario from GBX 500 to GBX 550 and gave the stock a “buy” rating in a report on Tuesday, October 21st. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of GBX 550.

Anpario Stock Down 2.5%

Shares of LON:ANP opened at GBX 497.40 on Monday. The firm has a market capitalization of £84.29 million, a PE ratio of 16.74 and a beta of 0.58. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15. Anpario has a 52-week low of GBX 286 and a 52-week high of GBX 536.50. The firm has a fifty day moving average of GBX 488 and a 200 day moving average of GBX 460.42.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.